This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nektar Therapeutics. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations by Erik Krogh-Jespersen
Introduction
Erik Krogh-Jespersen is an accomplished inventor based in Greenbrae, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuropathic pain. His innovative work has led to the development of novel compounds that target mu opioid receptors.
Latest Patents
One of Erik's notable patents is titled "Morphinan derivatives for the treatment of neuropathic pain." This invention relates to compounds that serve as ligands for mu opioid receptors. The patent also includes methods for preparing these compounds and pharmaceutical compositions containing them. In one or more embodiments of the invention, a compound according to Formula I is provided, along with pharmaceutically acceptable salts thereof, wherein R-R are as described in the patent.
Career Highlights
Erik is currently associated with Nektar Therapeutics, where he continues to advance his research and development efforts. His work focuses on creating effective treatments for pain management, which is a critical area in medical science.
Collaborations
Erik has collaborated with talented professionals in his field, including Neel Kumar Anand and Natalia Aurrecoechea. These collaborations have further enriched his research and contributed to the success of his projects.
Conclusion
Erik Krogh-Jespersen's innovative contributions to the pharmaceutical industry highlight his dedication to improving pain management therapies. His work continues to pave the way for advancements in medical treatments.